E-Learning Center
Join Our Network
OncoFacts

Follow Imedex on Twitter

Register for an upcoming conference!

Phone: +1 (678) 242 0906
registration@imedex.com

EIBD

4th European Conference: Perspectives in Inflammatory Bowel Diseases

26-27 June 2009

Copenhagen, Denmark

Marriott Copenhagen Hotel

Continuing Medical Education
Imedex, LLC is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

4th Annual European Conference: Perspectives in Inflammatory Bowel Diseases is designated for a maximum of 10 hours of European external CME credits. Each medical specialist should claim only those hours of credit that she/he actually spent in the educational activity.

EACCME credits are recognized by the American Medical Association toward the Physician’s Recognition Award (PRA). To convert EACCME credit to AMA PRA Category 1 credit, contact the AMA.

 

Who Should Attend
This activity is intended for gastroenterologists, radiologists, pathologists, surgeons, general physicians, trainees, clinical researchers, and other persons in the healthcare community with an interest in the treatment and management of patients with inflammatory bowel disease (IBD).

 

Objectives

After successfully completing this educational activity, participants should be able to:

  • Demonstrate thorough knowledge and clinical understanding of current and emerging therapies to manage both the in- and out-patient with IBD
  • Review the recent advances in the diagnosis and treatment of pediatric patients with IBD
  • Discuss the role of surgery in patients with IBD
  • Summarize current strategies to prevent, diagnose, and treat infectious complications of IBD
  • Evaluate the use of colonoscopy, upper endoscopy, and radiological imaging techniques to diagnose and manage IBD
  • Debate the timing and combination of biologics and immunomodulators for the treatment of IBD, as well as the relevance of mucosal healing as an important trial endpoint
  • Assess the prognostic importance of detecting dysplasia and/or polyps during cancer surveillance in patients with IBD
  • Improve patient care via increased understanding of the management of side effects incurred from various IBD therapies
  • Review the role of vaccinations on IBD patient populations

Willem A. Bemelman, MD, PhD
Academic Medical Center
Amsterdam, The Netherlands

Jean-Frédéric Colombel, MD
Hôpital Claude Huriez
Lille, France

Johanna C. Escher, MD, PhD
Sophia Children's Hospital
Rotterdam, The Netherlands

Subrata Ghosh, MD, FRCP
University of Calgary
Calgary, Alberta, Canada

Geert D'Haens, MD, PhD
Leuven University Hospital
Leuven, Belgium

Ralf Kiesslich, MD
University of Mainz
Mainz, Germany

Marc Lémann, MD, PhD
Hospital Saint- Louis
Paris, France

Richard P. MacDermott, MD
Albany Medical College
Albany, New York, United States

 

Philippe Marteau, MD, PhD
Lariboisière Hospital
Paris, France

Pierre Michetti, MD
Centre Hospitalier
Universitaire Vaudois
Lausanne, Switzerland

Pia Munkholm, MD, DMSci
Herlev University Hospital
Copenhagen, Denmark

Julián Panés, MD
Hospital Clinic
Barcelona, Spain

Miles Parkes, MBBS, FRCP
Addenbrooke's Hospital
Cambridge, United Kingdom

Paul Rutgeerts, MD, PhD
University Hospital Gasthuisberg
Leuven, Belgium

Andreas Schreyer, MD
University Hospital Regensburg
Regensburg, Germany

Gert Van Assche, MD, PhD
University Hospital Leuven
Leuven, Belgium

 

Friday, 26 June 2009

8:30 Welcome and introduction
Pia Munkholm, MD, DMSci and Paul Rutgeerts, MD, PhD

Session I:Current therapy of the outpatient with IBD
Moderator: Paul Rutgeerts, MD, PhD

8:40 Treatment of the outpatient with ulcerative colitis
Pia Munkholm, MD, DMSci

9:05 Treatment of the outpatient with Crohn's disease
Pierre Michetti, MD

9:30 Treatment of outpatient pediatric IBD
Johanna C. Escher, MD, PhD

9:55 Major side effects of IBD therapies
Marc Lémann, MD, PhD

10:20 Coffee break

 

Session II: Selected topics in IBD I
Moderator: Pia Munkholm, MD, DMSci

10:50 Advances in radiological imaging for IBD
Andreas Schreyer, MD

11:15 Advances in surgery in IBD
Willem A. Bemelman, MD, PhD

11:40 Use of currently available biologics in the treatment of IBD
Paul Rutgeerts, MD, PhD

12:05 Future biologic therapy for the treatment of IBD
Julián Panés, MD

12:30 Lunch break

 

Session III: State of the art lecture
Moderator: Pia Munkholm, MD, DMSci

14:00 What should I know and do about genetics in IBD?
Miles Parkes, MBBS, FRCP

 

Session IV: Case-based break-out sessions
(45 minutes for each, 15 minutes to move to different session, then another 45 minutes)

14:40 Challenges in treating the adolescent with IBD
Johanna C. Escher, MD, PhD and Pia Munkholm, MD, DMSci

Challenging medical/surgicalproblems in IBD
Willem A. Bemelman, MD, PhD and Julián Panés, MD

Treatment of the outpatient with severe IBD
Subrata Ghosh, MD, FRCP and Richard P. MacDermott, MD

15:25 Coffee break

15:40 Challenges in treating theadolescent with IBD
Johanna C. Escher, MD, PhD and Pia Munkholm, MD, DMSci

Challenging medical/surgicalproblems in IBD
Willem A. Bemelman, MD, PhD and Julián Panés, MD

Treatment of the outpatient withsevere IBD
Subrata Ghosh, MD, FRCP and Richard P. MacDermott, MD

16:25 Adjourn

Saturday, 27 June 2009

8:30 Welcome and introduction
Pia Munkholm, MD, DMSci and Paul Rutgeerts, MD, PhD

Session V: Selected topics in IBD I
Moderator: Philippe Marteau, MD, PhD

8:40 Incorporating new endoscopictechnologies into clinical practice
Ralf Kiesslich, MD

9:05 Treatment of common ano-rectalproblems in IBD
Geert D’Haens, MD, PhD

9:30 ECCO consensus on vaccinationrecommendations for IBD
Jean-Frédéric Colombel, MD

9:55 Use of antibiotics and probiotics in IBD
Philippe Marteau, MD, PhD

10:20 Coffee break

 

Session VI: Debates: Controversies in IBD
Moderator: Richard P. MacDermott, MD

DEBATE 1

10:50 Pro: Mucosal healing is a clinically relevant clinical endpoint in all patients with ulcerative colitis
Paul Rutgeerts, MD, PhD

11:05 Con: Mucosal healing is not a relevantclinical endpoint in any patient with ulcerative colitis
Subrata Ghosh, MD, FRCP

11:20 Question and answer and panel discussion

DEBATE 2:

11:40 Pro: Biologics should be used before immunomodulators in Crohn's disease
Geert D' Haens, MD, PhD

11:55 Con: Immunomodulators should beused before biologics in Crohn's disease
Gert Van Assche, MD, PhD

12:10 Question and answer and panel discussion

12:30 Lunch break

 

Session VII: Case-based break-out sessions
(45 minutes for each, 15 minutes to move to different session, then another 45 minutes)

14:00 Cancer surveillance in Crohn's disease andulcerative colitis:

What should we do about low gradedysplasia, polyps and DALMlesions?
Ralf Kiesslich, MD and Pierre Michetti, MD

Diagnosis, treatment, and prevention ofinfectious complications of IBD
Jean-Frédéric Colombel, MD and Philippe Marteau, MD, PhD

Treatment of the inpatient with severe IBD
Marc Lémann, MD, PhD and Gert Van Assche, MD, PhD

14:45 Coffee break

15:00 Cancer surveillance in Crohn's disease and ulcerative colitis:

What should we do about low gradedysplasia, polyps and DALM lesions?
Ralf Kiesslich, MD and Pierre Michetti, MD

Diagnosis, treatment, and prevention ofinfectious complications of IBD
Jean-Frédéric Colombel, MD and Philippe Marteau, MD, PhD

Treatment of the inpatient with severe IBD
Marc Lémann, MD, PhD and Gert Van Assche, MD, PhD

15:45 Adjourn

Registration Fees

Discounted €299 (If payment received by 30 April 2009)

Regular €399 (If payment received by 17 June 2009)

Full/Onsite: €499 (If payment received after 17 June 2009)

Nurses/Residents/Students* €200
*proof of eligibility must accompany registration

To Register: You may register online by 17 June 2009 or by calling Imedex at +1 (678) 242 0906.

To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.

The Registration and Information Desk will be staffed:
Friday, 26 June 2009 7:30 – 16:30
Saturday, 27 June 2009
7:30 – 16:00

 

Payment: To pre-register, registration and payment must be received no later than 17 June 2009. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the program is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card, or check, or wire transfer. Checks should be payable to Imedex. To pay via wire transfer, you must add €50 to each wire transaction to cover bank charges. Include the full name of the attendee and the name of the Congress: 4th Annual European Conference: Perspectives in Inflammatory Bowel Diseases #A070.01. An attendee is not registered until full payment is received.

Wire to: Bank of America, NA London, 1 Alie Street E1ADE London UK, Swift Code: BOFAGB22, Sort Code: 165050 Beneficiary: Bank of America Domestic Deposit #5687, Account #: 600895687029, Reference: Imedex, Inc. Account # 10726-118, IBAN: GB89 BOFA 1650 5095 6870 29.

Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, conference materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the program.

Cancellation: For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than 17 June 2009. The amount of registration fees remitted, minus a €90 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after 17 June 2009. Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this conference should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change.

Marriott Copenhagen Hotel
Kalvebod Brygge 5
KD-1560
Copenhagen, Denmark
Tel.: +45 88 99 00
Fax: +45 88 33 99 99
www.marriott.com/cphdk

With its windows on the quaint harbor in Denmark’s capital, the Copenhagen Marriott Hotel captures the charm of this fairytale city. Beyond the doors of this hotel are Copenhagen’s most beloved city sights: the Little Mermaid, Christiansborg Palace, the twinkling lights of Tivoli Gardens and Europe’s longest pedestrian street, the “Stroeget”, all within a 20-minute stroll. Inside, you’ll find spacious accommodations offering exquisite water and city views, luxurious bedding with down comforters and rich linens, a desk and high-speed Internet access. You’ll enjoy a well-equipped health club, sauna, steam bath and massage facilities featuring “Ole Henriksen” products. During your visit at this hotel, you’ll be enticed by superb dining, including the tempting Mediterranean cuisine of Terraneo Restaurant. The hotel is located 15 minutes from the Copenhagen Airport.

For the convenience of attendees, a limited number of rooms have been reserved until 24 May 2009 at a discounted rate of 1,899 DKK for a deluxe city view room, single or double occupancy and 2,099 DKK for a deluxe water view room, single or double occupancy.  The room rate includes a daily breakfast buffet and 25% VAT.  This rate is not guaranteed outside the conference date or after 24 May 2009. 

To reserve your room please contact the Marriott Copenhagen Hotel reservations department at +45 88 33 99 00.  To receive the group rate, callers must identify themselves as being with the 4th Annual European Conference: Clinical Perspectives in Inflammatory Bowel Diseases group.  Please visit www.imedex.com for the latest instructions on reserving a hotel room on line.  Reservation requests received after 24 May 2009 may not be guaranteed the group rate. 

 

Italian Participants: Fargo International Meetings & Conventions SRL has been appointed as the official agency for government authorization for Italian participants. You may contact them directly at:
Fargo International Meetings & Conventions SRL
Via Piattro Maroncelli 44/66, 50137 Firenze, Italy
Tel.: +39 055 600 555
Fax: +39 055 609 078

PDF

Dear Colleague,

We invite you to join us in Copenhagen for the 4th Annual European Conference: Perspectives in Inflammatory Bowel Diseases. We are happy to be holding our 4th annual meeting in this vibrant and charming city and are looking forward to another exceptional educational event.

At this meeting, specialists in the inflammatory bowel diseases, leading gastroenterologists and practicing clinicians will interact, review the state of the art and share the newest advances in the multidisciplinary management of IBD. We are particularly excited by our faculty, comprised of leading clinicians and researchers from around the world, who will share their expertise with you.

By popular request, expanded case-based clinical breakout sessions will provide valuable and practical take-home information relevant to your own practice. New debates will cover controversial issues in the management of patients with IBD, and a featured lecture will cover what you should know and do about genetics in IBD. Reviews of new technologies and future therapies will give you all the information you need to optimize the care of your patients for 2009 and beyond.

Sincerely,
Pia Munkholm, MD, DMSci
Paul Rutgeerts, MD, PhD

Chairs

 

ORGANIZER

Imedex
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com

 

Conference Summary:
This meeting allows specialists in the inflammatory bowel diseases, leading gastroenterologists and practicing clinicians to interact, review the state of the art and share the newest advances in the multidisciplinary management of IBD. An expert faculty of leading clinicians and researchers will participate in the scientific program. By popular request, expanded case-based clinical breakout sessions will provide valuable and practical take-home information relevant to your own practice. New debates will cover controversial issues in the management of patients with IBD.

 

High Praise from Attendees:

  • “This is one of the best conferences I have ever attended”
  • “Excellent speakers and presentations”
  • “A nice mix of clinical useful information and talks on science, research and future”
  • “Excellent overviews and expert’s opinion”
  • “Thanks a lot for a very informative conference. It opened my clinical approach to IBD”
  • “A very useful, warm and enjoyable conference”
  • “The best IBD conference that I have been to in a long time”

Copenhagen, Denmark
Copenhagen is a city with much charm, as reflected in its canals, narrow streets, and old houses. From its humble origins as a fishing village, to its heyday as the glittering capital of the Danish Empire, to its current position as one of the world’s premier design capitals and Scandinavia’s pre-eminent city, the stories and characters of Copenhagen’s history can be discovered in its sumptuous palaces, copper-roofed town houses and atmospheric cobbled squares. Surveys show that Danes are the happiest people in the world, and June is a great time to share in the joy!

 

The following company has provided an educational grant in support of this conference:

swedish orphan international

Several options are available to companies interested in supporting this Congress. For more information, please contact Imedex at +1(770) 751 7332, or by email at cme@imedex.com.

Information coming soon.